Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (KCT0012722) titled 'Feasibility of combination therapy with low-dose statin and ezetimibe in patients with minimal subclinical atherosclerosis (MINI-STAR Trial)' on Oct. 1.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Yonsei University Yongin Severance Hospital
Condition:
Diseases of the circulatory system
Intervention:
Drug : In this study, patients with minimal subclinical atherosclerosis identified by imaging (CCTA, CAG, or carotid sonography) will be randomized to receive one of three low-dose statin/ezetimib...